Dividend Aristocrats in Disguise: How 10 Small-Caps Outlast Market StormsGlobal Report·Oct 20, 2026 at 10:15 AMWWD+0.98%SWRD+16.00%
Xeris Biopharma Reports Cortisol Normalization With Recorlev in Cushing's Syndrome Case StudyPUBT·Oct 15, 2026 at 12:04 PMXERS+1.37%
Xeris Pharmaceuticals Files Patent Suits to Protect KEVEYISTip Ranks·Oct 14, 2026 at 11:28 AMXERS+1.37%
Xeris Biopharma files New Jersey patent suits after KEVEYIS patent grantPUBT·Oct 14, 2026 at 11:08 AMXERS+1.37%
Xeris Biopharma Holdings (XERS) After Record Quarter And Debt Retirement Still Looks UndervaluedSimplywall·Oct 9, 2026 at 03:13 PMXERS+1.37%
Full Transcript: Xeris Biopharma Holdings Q2 2026 Earnings Callbenzinga_article·Oct 6, 2026 at 10:24 AMXERS+1.37%
Delisting Dominoes: How Blue Lasers and Biotech Breakthroughs Expose Small-Cap Fault LinesGlobal Report·Oct 6, 2026 at 10:14 AMBURU-9.07%NTSK+6.05%
Xeris Biopharma (NASDAQ:XERS) Shares Climb 9.2% - Still a Buy?Market Beat·Oct 5, 2026 at 04:41 PMXERS+1.37%
Xeris Biopharma (NASDAQ:XERS) Stock: Insider Steven Pieper Sells 5,000 SharesMarket Beat·Oct 2, 2026 at 09:23 PMXERS+1.37%
Xeris Biopharma (NASDAQ:XERS) Insider Kevin Mcculloch Sells 15,000 Shares of StockMarket Beat·Oct 2, 2026 at 09:08 PMXERS+1.37%
Xeris Biopharma grants inducement equity awards covering 352,170 shares to 60 new employeesPUBT·Oct 2, 2026 at 09:00 PMXERS+1.37%
Xeris Biopharma Chief Legal Officer Beth Hecht disposes of 16,666 shares worth $156,797PUBT·Oct 2, 2026 at 08:54 PMXERS+1.37%
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | XERS Stock NewsStockTitan·Oct 2, 2026 at 01:00 PMXERS+1.37%
